Literature DB >> 18696040

[German Association for Bladder Cancer Research].

M Retz1, A Hartmann, A Merseburger, P Olbert, R Stoehr, R Nawroth.   

Abstract

The "German Association for Bladder Cancer Research" was founded in May 2008 by urologists, scientists, and pathologists. The purpose of this association is to concentrate research activities on a national level, to facilitate collaborations with an interdisciplinary background, and to define standard methodology for a higher quality of scientific results. Additionally, a national database for bladder cancer specimens will be initiated. The website http://www.forschungsverbund-blasenkarzinom.de will provide further information about the German Association for Bladder Cancer Research.

Entities:  

Mesh:

Year:  2008        PMID: 18696040     DOI: 10.1007/s00120-008-1826-y

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  4 in total

1.  Frequent microsatellite instability in sporadic tumors of the upper urinary tract.

Authors:  Arndt Hartmann; Livia Zanardo; Tina Bocker-Edmonston; Hagen Blaszyk; Wolfgang Dietmaier; Robert Stoehr; John C Cheville; Kerstin Junker; Wolf Wieland; Ruth Knuechel; Josef Rueschoff; Ferdinand Hofstaedter; Richard Fishel
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

2.  Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era.

Authors:  Richard E Hautmann; Jürgen E Gschwend; Robert C de Petriconi; Martina Kron; Bjoern G Volkmer
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

3.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Authors:  Richard J Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Christian Bouffioux; Louis Denis; Donald W W Newling; Karlheinz Kurth
Journal:  Eur Urol       Date:  2006-01-17       Impact factor: 20.096

4.  Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.

Authors:  Hans von der Maase; Lisa Sengelov; James T Roberts; Sergio Ricci; Luigi Dogliotti; T Oliver; Malcolm J Moore; Annamaria Zimmermann; Michael Arning
Journal:  J Clin Oncol       Date:  2005-07-20       Impact factor: 44.544

  4 in total
  1 in total

1.  [Bladder cancer in focus: update 2012 of the German Bladder Cancer Association].

Authors:  B Keck; A S Merseburger; R Stöhr; S Füssel; M J Hoffmann; S Schmid; P Olbert; A Hartmann; R Nawroth
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.